<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03607760</url>
  </required_header>
  <id_info>
    <org_study_id>ECMO</org_study_id>
    <nct_id>NCT03607760</nct_id>
  </id_info>
  <brief_title>Extracorporeal Membrane Oxygenation (ECMO)</brief_title>
  <official_title>Extracorporeal Membrane Oxygenation (ECMO) and Neonatal Outcomes:a Retrospective Multicenters Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Daping Hospital and the Research Institute of Surgery of the Third Military Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bayi Children's Hospital Affiliated to PLA Army General Hospital, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital of Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hunan Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Hospital of Jilin University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing 302 Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>the general navy hospital of the PLA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zhengzhou Children's Hospital, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guangzhou Women and Children's Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Daping Hospital and the Research Institute of Surgery of the Third Military Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Since the 1970s, extracorporeal membrane oxygenation (ECMO) support has been used to support&#xD;
      gas exchange for children with severe acute respiratory failure who fail mechanical&#xD;
      ventilation. ECMO is more expensive than each of these other procedures.But its action is&#xD;
      unclear&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Since 1974, eight randomized controlled trials have been reported in ECMO for respiratory&#xD;
      failure, and none have included non-neonatal pediatric patients. Cochrane systematic reviews&#xD;
      of this evidence concluded that ECMO for neonatal respiratory failure had a survival&#xD;
      advantage, but there was insufficient evidence to demonstrate a survival advantage for ECMO&#xD;
      used to support respiratory failure in adults. Moreover, these trials were performed prior to&#xD;
      2009, and since then advances in ECMO technology have enhanced the delivery of ECMO support,&#xD;
      and new research has changed conventional management of severe acute respiratory distress&#xD;
      syndrome (ARDS)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 11, 2018</start_date>
  <completion_date type="Actual">April 4, 2019</completion_date>
  <primary_completion_date type="Actual">March 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>in-hospital mortality</measure>
    <time_frame>36 weeks' gestational age or before discharge from hospital</time_frame>
    <description>the patients died</description>
  </primary_outcome>
  <primary_outcome>
    <measure>28 days' mortality</measure>
    <time_frame>28 days</time_frame>
    <description>the patients died</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neonatal necrotizing enterocolitis</measure>
    <time_frame>36 weeks' gestational age or before discharge from hospital</time_frame>
    <description>Neonatal necrotizing enterocolitis was diagnosed after extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraventricular hemorrhage</measure>
    <time_frame>36 weeks' gestational age or before discharge from hospital</time_frame>
    <description>Intraventricular hemorrhage was diagnosed after extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>bronchopulmonary dysplasia</measure>
    <time_frame>36 weeks' gestational age or before discharge from hospital</time_frame>
    <description>bronchopulmonary dysplasia was diagnosed after extubation</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">300</enrollment>
  <condition>Extracorporeal Membrane Oxygenation</condition>
  <arm_group>
    <arm_group_label>ECMO</arm_group_label>
    <description>severe respiratory failure with ECMO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional mechanical ventilation</arm_group_label>
    <description>severe respiratory failure with conventional mechanical ventilation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ECMO</intervention_name>
    <description>the patients with severe respiratory failure were supported by ECMO</description>
    <arm_group_label>ECMO</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>conventional mechanical ventilation</intervention_name>
    <description>the patients with severe respiratory failure were supported by conventional mechanical ventilation</description>
    <arm_group_label>conventional mechanical ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All the patients will be eligible only when they reach the cutting line in the following:&#xD;
&#xD;
        Gestational age &gt; 36 weeks, birth weight &gt; 2 kg, day post-birth &lt; 28 days.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        1. ECMO group:&#xD;
&#xD;
          1. Oxygenation Index &gt; 40 for &gt;4 hours&#xD;
&#xD;
          2. Failure to wean from 100% oxygen despite prolonged (&gt; 48h) maximal medical therapy or&#xD;
             persistent episodes of decompensation&#xD;
&#xD;
          3. Severe hypoxic respiratory failure with acute decompensation (PaO2 &lt;40) unresponsive&#xD;
             to intervention&#xD;
&#xD;
          4. Severe pulmonary hypertension with evidence of right ventricular dysfunction and/or&#xD;
             left ventricular dysfunction. The pulmonary artery pressure &gt; 60mmHg evaluated by the&#xD;
             Echo, arterial duct keeps open and the blood flow was either by-level shunt or&#xD;
             completely shunt from right side to left side.&#xD;
&#xD;
        2. Non-ECMO group:&#xD;
&#xD;
          1. Oxygenation Index &gt; 16 and reach the Montreux definition of severe respiratory&#xD;
             distress syndrome&#xD;
&#xD;
          2. Vasoactive-inotropic score (VIS) ≥ 40 [VIS=dopamine dose (μg/kg/min)×1 + dobutamine&#xD;
             dose (μg/kg/min)×1 + milrinone dose (μg/kg/min)×10 + amrinone dose (μg/kg/min)×10 +&#xD;
             epinephrine dose (μg/kg/min)×100 + isoprenaline dose (μg/kg/min)×100]&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Gestational age &lt; 36 weeks, birth weight &lt; 2 kg, day post-birth &gt; 28 days.&#xD;
&#xD;
          2. lethal chromosomal disorder (includes trisomy 13, 18 but not 21) or any other lethal&#xD;
             anomaly&#xD;
&#xD;
          3. irreversible brain damage&#xD;
&#xD;
          4. uncontrolled bleeding&#xD;
&#xD;
          5. Grade III or greater intraventricular hemorrhage&#xD;
&#xD;
          6. ventilator days ≥ 15 days.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Month</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Daping Hospital and the Research Institute of Surgery of the Third Military Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400042</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>July 24, 2018</study_first_submitted>
  <study_first_submitted_qc>July 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 31, 2018</study_first_posted>
  <last_update_submitted>April 8, 2019</last_update_submitted>
  <last_update_submitted_qc>April 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Daping Hospital and the Research Institute of Surgery of the Third Military Medical University</investigator_affiliation>
    <investigator_full_name>Chen Long,MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

